Cytek Investor Presentation Deck slide image

Cytek Investor Presentation Deck

Cytek' FSP Platform versus Other Technologies Conventional Flow Cytometry Biomarkers / Parameters (>40 biomarkers)¹ Sensitivity (nanoparticle detection) Throughput (>30K cell/second) Footprint (<150K cm³) Sorting Capability Cost Performance² 1. Based on peer-reviewed publications 2. CYTEK TRANSCEND THE CONVENTIONAL X X Spectral Flow Cytometry X X X X X Cost-to-Performance reflects performance based on accessible biomarkers, sensitivity, throughput and sorting capabilities, relative to costs associated with instruments, consumables, time, labor and ability to upgrade over time Mass Cytometry X X X X X CYTEK TRANSCEND THE CONVENTIONAL 15
View entire presentation